BioSyntech, Inc.
BSYI
$0.00
$0.000.00%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | 500.00 | 109.90K | 47.20K | 19.00K | 3.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 500.00 | 109.90K | 47.20K | 19.00K | 3.90K |
| Cost of Revenue | 900.00 | 35.50K | 19.20K | 5.80K | 1.30K |
| Gross Profit | -400.00 | 74.40K | 28.00K | 13.30K | 2.60K |
| SG&A Expenses | 604.10K | 1.30M | 697.10K | 613.10K | 517.50K |
| Depreciation & Amortization | 123.60K | 86.10K | 103.30K | 90.30K | 99.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.48M | 2.15M | 1.31M | 1.15M | 1.73M |
| Operating Income | -1.47M | -2.04M | -1.26M | -1.13M | -1.73M |
| Income Before Tax | -3.20M | -3.30M | -2.28M | -2.47M | -3.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.20M | -3.30M | -2.28M | -2.47M | -3.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.20M | -3.30M | -2.28M | -2.47M | -3.73M |
| EBIT | -1.47M | -2.04M | -1.26M | -1.13M | -1.73M |
| EBITDA | -1.40M | -1.97M | -1.18M | -1.10M | -1.66M |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 106.08M | 105.44M | 101.32M | 96.14M | 96.09M |
| Average Diluted Shares Outstanding | 106.08M | 105.44M | 101.32M | 96.14M | 96.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
